Decode and Pfizer to Analyze Lupus Patient Genomes for Disease-Associated Variants | GenomeWeb

Decode Genetics and Pfizer are collaborating to discover sequence variants associated with clinical phenotypes of systemic lupus erythematosis, Decode said this week.

Over the next 18 months, the partners will jointly analyze the genomes of an undisclosed number of lupus patients, with the aim to find sequence variants that could help them understand existing drug targets and identify novel targets. Another goal is to develop tools for patient stratification and companion diagnostics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.